Sector
PharmaceuticalsOpen
₹22.05Prev. Close
₹23.15Turnover(Lac.)
₹6.56Day's High
₹24Day's Low
₹22.0552 Week's High
₹052 Week's Low
₹0Book Value
₹0Face Value
₹10Mkt Cap (₹ Cr.)
58.67P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Equity Capital | 25.96 | 25.96 | 25.96 | 25.96 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -51.5 | -43.39 | -20.91 | -20.97 |
Net Worth | -25.54 | -17.43 | 5.05 | 4.99 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Revenue | 23.81 | 4.12 | 6.32 | 4.53 |
yoy growth (%) | 477.1 | -34.71 | 39.33 | -23.89 |
Raw materials | -12.52 | -1.65 | -2.36 | -1.81 |
As % of sales | 52.58 | 40.21 | 37.37 | 40 |
Employee costs | -11.46 | -1.01 | -0.86 | -0.57 |
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Profit before tax | -22.46 | 0.18 | -3.23 | -3.45 |
Depreciation | -0.04 | -0.04 | -4.63 | -4.64 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | -21.91 | 0.14 | 1.37 | 1.3 |
Other operating items |
| Y/e 31 Mar | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 477.1 | -34.71 | 39.33 | -23.89 |
Op profit growth | 40,892.21 | -104.85 | 40.21 | 407.25 |
EBIT growth | -11,780.54 | -105.93 | -6.44 | -18.22 |
Net profit growth | -11,936.61 | -105.85 | -6.36 | -18.22 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Gautam Doshi
Director
Rajesh Laddha
Independent Director
N L Bhatia
Company Secretary
Maneesh Sharma
Director
Rashida Najmi
Piramal Tower,
Ganpatrao Kadam Marg Lower Par,
Maharashtra - 400013
Tel: 91-22-30467953
Website: -
Email: [email protected]
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: [email protected]
Summary
A demerged entity from Piramal Healthcare Limited (Formerly known as Nicholas Piramal India Limited) is now known as Piramal Life Sciences Limited (PLSL). Incorporated on 27th June 2001 under the name...
Read More
Reports by Piramal Phytocare Ltd Merged
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.